Alex Broomfield MBBS, MSC

Dr. Alex Broomfield is a consultant in pediatric inherited metabolic diseases at the Willink Unit at Saint Mary’s Hospital. His major research interest is therapy for lysosomal storage diseases (LSD’s) and leukodystrophies. He received his medical training at Saint Mary’s Hospital Medical School, Imperial College, with a subsequent MSC in the immunology of infectious disease at UCL. He did his metabolic training at Pedulbury Children’s Hospital and Great Ormond Street Hospital in London. Dr. Broomfield has been working at the Willink Biochemical Genetics Unit in Manchester since February 2014. The Willink Unit is now part of the Manchester Centre for Genomic Medicine at Saint Mary’s Hospital.

Dr. Broomfield has been actively involved in international multicentre trials of novel therapies for LSD’s. He is currently the principal or sub-investigator in a number of LSD trials. He is an author of over 40 peer-reviewed papers and 1 book chapter.

Alexander Broomfield currently works at the Department of Clinical Genetics, Central Manchester University Hospitals NHS Foundation Trust. Alexander does research in Pediatrics. Their current project is 'Mucopolysaccharidosis type I'.